Bihzuun Research | Institutional Equity Report
Cboe Global Markets, Inc. (NASDAQ: CBOE) — July 31, 2026
| Field | Detail |
|---|---|
| Ticker | CBOE (NASDAQ) |
| Bihzuun Research Score (BRS) |
★ ★ ★ ★ ★ Strong Buy |
| Bihzuun Research Rating (BRR) | Constructive — Conditional Accumulation |
| Current Price | $296.52 |
| 12-Month Base Case Target | $320–$330 |
| Composite Median (Comparable-Anchored) | $313.80 |
| Margin of Safety (Composite) | 5.8% |
| DCF Intrinsic Value (Declining Growth) | $458.84 (bear–bull: $435.51–$483.14) |
| Investment Timeframe | 12 Months (with 24-month optionality) |
| Confidence Level | Moderate (55–60%) |
| Report Date | July 31, 2026 — Q2 2026 Earnings Day |
⚠ IMMINENT EVENT: Cboe Global Markets reports Q2 2026 earnings before market open today, July 31, 2026. This report should be read in its entirety with that catalyst as the immediate analytical lens. All valuation anchors, risk assessments, and positioning guidance herein are subject to intraday revision pending earnings release and management commentary.
1. Business Overview & Economic Moat
Franchise Architecture
Cboe Global Markets operates as the world’s largest options exchange and a leading global derivatives and securities marketplace. Its business spans four principal revenue segments: Options (the dominant contributor), North American Equities, Europe and Asia Pacific, and a structurally expanding Data and Access Solutions division. The company generated $4.714 billion in total revenue across the most recent fiscal period, underpinning a market position that is simultaneously entrenched and evolving.
What distinguishes Cboe from conventional exchange operators is the qualitative character of its competitive position. Cboe does not merely operate infrastructure — it controls a constellation of proprietary index franchises, centrally cleared liquidity pools, and high-margin data licensing streams that collectively function as compounding, defensible toll roads. The institutional framing here is critical: Cboe’s revenue is not purely transactional and therefore not purely cyclical. Its Data and Access Solutions business now accounts for over 30% of net revenue, a proportion that provides genuine earnings floor support during low-volatility periods and increasingly resembles the recurring revenue profile associated with software or financial data businesses rather than traditional exchange operators.
The Three Pillars of Moat
- Proprietary Index Franchise Exclusivity: The VIX and SPX options complex is the crown jewel of Cboe’s moat architecture. Contractual arrangements with S&P Global create a structural barrier to replication that no competitor has circumvented in over three decades. These contracts cannot be listed elsewhere, and their liquidity is so deeply consolidated on Cboe’s venues that even well-capitalised rivals lack the critical mass to fracture the network. This is not a moat maintained by operational efficiency alone — it is a legally reinforced quasi-monopoly on the world’s most actively traded volatility and index derivatives instruments.
- Network Liquidity Effects: Exchange moats are classically self-reinforcing. Buyers attract sellers, tighter spreads attract more participants, and volume begets volume. Cboe’s options network has reached a scale at which defection to an alternative venue imposes immediate and visible execution cost on market participants. The 0DTE (zero days to expiration) product cycle, still in its mid-innings phase, exemplifies how structural liquidity advantages can be monetised through product innovation without requiring new infrastructure investment.
- Recurring Data Revenue: The Data and Access Solutions segment represents the most underappreciated component of Cboe’s moat. Proprietary market data, analytics, and connectivity services carry subscription-like revenue characteristics — predictable, high-margin, and contractually sticky. At an EBITDA margin approaching 60% across the enterprise, this is the hallmark not of a capital-intensive infrastructure operator but of a genuine network-effects business whose moat compounds through data accumulation and analytical differentiation.
Strategic Transformation — The Prediction Markets Pivot
Cboe has launched “Cboe Predicts,” its first-generation prediction markets product offering binary option contracts based on the Mini-S&P 500 Index. More ambitiously, the company has filed with the SEC to list binary options tied to corporate performance metrics — covering more than 100 metrics across 23 major companies including SpaceX revenue, Nvidia data center sales, and Apple iPhone shipments. If approved, these contracts would be centrally cleared by the OCC and distributed through existing brokerage infrastructure, giving Cboe a structural distribution advantage that fintech prediction platforms cannot replicate at equivalent scale or regulatory credibility.
This matters strategically because it repositions Cboe from a potential victim of prediction market disruption into an aggressive, regulated first mover within that category. The irony of Cboe’s summer 2026 narrative — shares falling 25% from highs on prediction market competition fears — is that the company’s regulatory infrastructure, clearing relationships, and broker distribution make it uniquely positioned to monetise the very product category that spooked investors. This pivot is not without execution risk (addressed in Section 6), but the strategic logic is coherent and the competitive positioning is superior to fintech entrants.
2. Financial Deep Dive
Income Quality and Profitability
| Metric | Value | Bihzuun Commentary |
|---|---|---|
| Total Revenue | $4.714B | Diversified across options, equities, data, and international |
| Net Income | $1.100B | Solid absolute conversion; quality of earnings supported by recurring streams |
| Net Margin | 23.3% | Respectable for a diversified derivatives franchise carrying M&A overhead |
| Return on Equity | 21.4% | Reflects genuine franchise pricing power, not financial engineering |
| EPS | $10.46 | Supports 12-month target range on forward P/E of ~31x; industry at 20.54x |
| EBITDA Margin (Enterprise) | ~60% | Industry-leading; network-effects business, not capital-intensive infrastructure |
| Long-Term Debt | $1.564B (23.3% ratio) | Modest leverage; does not appear to strain debt service capacity |
| Dividend Yield | 0.97% | Nominal; total return thesis depends on price appreciation |
| Payout Ratio | 27.5% | Conservative; retained capital available for buybacks, acquisitions, product investment |
| Equity Base | $5.138B | Solid foundation underpinning 21.4% ROE |
Scorecard Summary
| Scorecard Dimension | Score (out of 100) | Interpretation |
|---|---|---|
| Balance Sheet Health | 71 | Manageable leverage; capital structure sound but not pristine |
| Growth Consistency | 100 | Revenue and earnings expansion has been sustained and strong; a standout attribute |
| Valuation Attractiveness | 19 | Loudest single warning; priced for considerable future execution across traditional metrics |
| Income Profile | 24 | Low yield concentrates risk in price appreciation; not an income instrument |
Capital Allocation Philosophy
Cboe’s capital allocation posture is disciplined and growth-oriented. With a payout ratio of just 27.5%, the company retains the majority of earnings for organic reinvestment, bolt-on M&A, and share repurchases. The TMX divestiture of its Australian and Canadian equities businesses for US$300 million (if and when regulatory approvals are secured) represents both a capital unlock and a management bandwidth reallocation — sharpening focus on higher-margin derivatives and data franchises where Cboe’s competitive differentiation is most durable. The 0.97% dividend yield is nominal, and income-oriented investors should be clear that this is a total-return, growth-compounding vehicle rather than a yield instrument.
Cross-referencing with the valuation section: the perfect growth score of 100 and the conservative payout ratio together explain why the DCF arrives at $458.84 — the model is capturing a consistent, capital-efficient compounder. The tension is that this premium is sustained only if growth execution continues, making Q2 2026 today’s critical validation event.
3. Multi-Model Valuation Assessment
Model Output Summary
| Valuation Model | Output / Status | Weight in Synthesis |
|---|---|---|
| DCF (Declining Growth) | $458.84 (range: $435.51–$483.14) | Meaningful but conditional on growth durability |
| Comparable Company Analysis | $313.80 (composite median) | Operative anchor; highest weight in synthesis |
| Graham Number | $107.23 | Illustrative only; underscores distance from book-value-anchored intrinsic value |
| DDM (Dividend Discount) | Not applicable | Growth rates exceed model constraints; signal that Cboe is priced as a growth entity |
| Earnings Power Value (EPV) | Not applicable | Same constraint as DDM; not a steady-state income vehicle |
| Forward P/E (12-Month) | 21.27x vs. industry 20.54x | Modest premium; sustainable if Q2 growth trajectory confirmed |
| Composite Median (Operative) | $313.80 | Base case anchor |
| Margin of Safety (Current Price vs. Composite) | 5.8% | Thin by conventional standards; demands execution delivery |
Synthesis and Interpretation
The multi-model valuation picture is intentionally complex and should not be reduced to a single number. The critical interpretive frame is the divergence between the DCF output ($458.84) and the comparable-based composite ($313.80), separated by a gap of approximately $145. This gap is not an error — it reflects a fundamental tension between how the market currently prices Cboe’s peer group (the comparable anchor) and what a pure discounted cash flow model assigns to Cboe’s standalone growth trajectory as a best-in-class compounder.
The Graham Number of $107.23 should not be read as a bear case target. It is an artifact of applying a book-value-anchored framework to a franchise business whose earnings power is structurally detached from tangible book value. Its value is diagnostic: it confirms how far Cboe’s current valuation has traveled from asset-based anchors, quantifying the premium the market assigns to franchise quality, network effects, and growth trajectory. Sophisticated institutional investors do not use the Graham Number as a sell signal for exchange operators — they use it as a reminder that the investment thesis is entirely predicated on sustained earnings growth and competitive moat preservation.
The 12-month base case of $320–$330 is grounded in the comparable composite with a modest upward drift assumption embedded in continued 0DTE volume growth, Data and Access Solutions expansion, and Cboe Predicts product adoption. Downside scenario to $290–$295 (at or below current price) is plausible if today’s Q2 earnings disappoint on revenue or if management guidance is cautious on prediction markets volume. Upside scenario to $340–$350 is achievable if earnings beat is accompanied by constructive Cboe Predicts guidance and any positive TMX regulatory update.
4. Competitive & Industry Analysis
Competitive Landscape
| Competitor | Primary Arena | Threat Level | Key Dynamic |
|---|---|---|---|
| CME Group | U.S. Futures & Institutional Hedging | Established / Managed | Dominant in futures; competes on price, not franchise quality in Cboe’s core |
| Intercontinental Exchange (ICE) | NYSE Listings, Energy Derivatives, Mortgage Tech | Established / Managed | Now launching futures tied to Fed policy decisions; direct product category overlap emerging |
| Nasdaq Options Network | U.S. Options | Established / Managed | ~25% U.S. options market share; SEC approval secured for binary options on Nasdaq indexes in 2026 |
| Kalshi | Prediction / Event Contracts | Elevated / Structurally Disruptive | CFTC approved Bitcoin perpetual futures; combined Kalshi+Polymarket monthly volume ~$24B (April 2026) vs. <$5B (Sept 2025) |
| Polymarket | Decentralised Prediction Markets | Elevated / Monitoring | Seeking CFTC approval; crypto-native infrastructure limits institutional distribution but volume growth is notable |
Market Share and Structural Dynamics
The competitive map has structurally expanded in 2026. The most important analytical insight is that every major exchange operator — Nasdaq, ICE, and Cboe — is racing simultaneously to capture the event-contract and binary options market that platforms like Kalshi and Polymarket pioneered. This is not a story of incumbents being disrupted and failing to respond. It is a story of incumbents mobilising their most durable competitive advantages — clearing infrastructure, broker distribution, regulatory credibility, and balance sheet depth — to colonise a new product category that has already demonstrated genuine and accelerating retail demand.
The volume acceleration in prediction markets (from under $5 billion in September 2025 to approximately $24 billion in April 2026) is the kind of demand signal that tends to attract rather than repel regulated exchange competition. Cboe’s regulatory credibility and OCC clearing relationships give it a distribution pathway that Kalshi and Polymarket have spent years attempting to establish. The market’s initial 25% price drawdown on disruption fears was, in retrospect, a mispricing of Cboe’s strategic positioning as an aggressive first mover within the category — not a victim of it. Investors entering at or near current levels are effectively being compensated, through a modestly below-composite valuation, for execution uncertainty that fundamentally underestimates Cboe’s structural advantages in this transition.
Market Regime Context
The current neutral regime — characterised by VIX normalisation, a steepening yield curve, and sector rotation from mega-cap technology toward cyclicals and financials — is structurally constructive for Cboe in a relative sense. Exchange operators are cyclical-financial hybrids that tend to outperform during periods of elevated capital reallocation, because rotation itself generates transaction volume. The 2016–2017 reflation rotation analog is instructive: financials and infrastructure names significantly outperformed index-level returns as the steepening curve repriced earnings multiples and asset reallocation elevated derivatives hedging demand. Cboe is not a pure rate vehicle, but its sensitivity to trading volumes, data demand, and capital market activity creates a beta-to-regime that is constructively aligned with the current environment.
5. Risk Mapping
Risk Register
| Risk Category | Specific Risk | Severity | Probability | Mitigation / Offset |
|---|---|---|---|---|
| Macro / Volume | Hard landing scenario compresses VIX; reduces options premium activity and transaction revenue | High | Moderate | Data & Access Solutions provide recurring revenue floor; 0DTE volume partially independent of VIX levels |
| Macro / Rate | Aggressive Fed cuts compress volatility expectations; muted options market activity | High | Moderate | Steepening curve currently constructive; Jackson Hole (Aug 27–29) is a critical event for rate trajectory |
| Competitive / Structural | CFTC / SEC approvals for Kalshi and Polymarket accelerate prediction market competition before Cboe Predicts scales | Medium | Moderate | Cboe’s OCC clearing, broker distribution, and regulatory standing provide structural distribution advantages |
| Execution / Product | Cboe Predicts fails to attract sustainable volume; history of 2008 binary options failure is an operative precedent | High | Low–Moderate | Retail participation structurally stronger than 2008; brokerage account distribution more accessible; but management must demonstrate volume traction |
| Regulatory / Binary | SEC rejects or materially delays binary KPI options filing (SpaceX, Nvidia, Apple metrics) | Medium | Moderate | Novel regulatory territory; OCC clearing framework enhances approval probability but timeline uncertain |
| Regulatory / Divestiture | TMX divestiture fails to obtain regulatory approvals in Australia and/or Canada; $300M cash inflow deferred or lost | Medium | Low | Two-jurisdiction approval process introduces binary event risk but deal is strategically aligned with regulators’ market structure objectives |
| Valuation / Execution | Growth trajectory deteriorates; DCF premium collapses toward comparable anchor or below | High | Low–Moderate | Perfect historical growth score provides track record support, but forward execution is not guaranteed |
| Income / Total Return | Income score of 24/100 reflects near-total dependence on price appreciation; no yield cushion | Medium | Structural | Acceptable for growth-oriented institutional mandates; incompatible with income-mandated portfolios |
| Event / Earnings | Q2 2026 earnings (today) miss consensus; guidance cautious; stock re-rates below composite median | High | Low (given 5-quarter beat track record and Q1 +$0.33 beat) | Average 5.35% positive earnings surprise; Q1 2026 beat of $0.33 on EPS; Q2 revenue consensus at $708.5M (+20.6% YoY) |
6. Catalyst Monitor
Upcoming Catalysts — Priority Ranked
| Date / Window | Catalyst | Priority | Expected Impact Direction |
|---|---|---|---|
| TODAY — July 31, 2026 | Q2 2026 Earnings Release (pre-market). Consensus: $708.5M revenue (+20.6% YoY), EPS $3.45. Watch: Cboe Predicts adoption commentary, TMX update, Kalshi competitive response language. | ⚠ IMMINENT / CRITICAL | Binary; upside to $340–$350 on beat + constructive guidance; downside to $285–$295 on miss or cautious tone |
| August 7, 2026 | July Nonfarm Payrolls Report. June print of +57,000 was notably weak. A second consecutive weak print increases hard landing probability and pressure on VIX-dependent revenue. | HIGH | Negative if weak; constructive if resilient |
| August 12, 2026 | CPI Release. Elevated inflation would complicate Fed path; disinflation would support rate stability and options market normalisation. | HIGH | Directional for financial sector broadly |
| ~August 29, 2026 | TMX Divestiture — Regulatory Approval Update (Australia / Canada). Positive approval confirms US$300M cash inflow and validates capital reallocation narrative. | HIGH | Positive on approval; neutral on delay; negative on rejection |
| August 27–29, 2026 | Jackson Hole Symposium. Fed Chair Kevin Warsh expected to speak. Most consequential macro policy signal for rate-sensitive financial sector pricing over the next 60 days. | CRITICAL | Material re-pricing risk for financial sector; hawkish = negative for growth multiples; dovish = constructive |
| September 2026 | FOMC Meeting (includes Summary of Economic Projections / Dot Plot). Directly re-prices earnings multiples for financial sector constituents including Cboe. | HIGH | Trajectory-dependent; key for 12-month return pathway |
| Ongoing / Rolling | SEC ruling on binary KPI options filing (SpaceX revenue, Nvidia data center, Apple iPhone metrics). Approval would represent a step-change expansion in Cboe’s addressable prediction markets TAM. | HIGH | Materially positive on approval; neutral on delay |
| Ongoing / Rolling | Cboe Predicts volume data (monthly). The operative measure of prediction markets product adoption. Management credibility and re-rating depend on demonstrating sustainable, growing volume. | MEDIUM–HIGH | Accumulating positive signal if volume scales; negative if stagnation |
| Ongoing / Rolling | CFTC / Polymarket approval decision. If Polymarket receives CFTC approval with broad contract scope, competitive pressure on Cboe Predicts intensifies in the short term before Cboe’s distribution advantages assert. | MEDIUM | Short-term negative on approval; medium-term neutral as Cboe distribution advantages accumulate |
| July 13, 2026 (live) | 23×5 U.S. Equities Trading Launch (EDGX) + Extended Pre/Post Market Options Hours. Incremental revenue optionality; signals continued product velocity from management. | MEDIUM | Incrementally positive; volume ramp will take time |
7. Investment Verdict
BRS Rating & BRR Posture
| Component | Assessment |
|---|---|
| Bihzuun Research Score (BRS) |
★ ★ ★ ★ ★ Strong Buy |
| Bihzuun Research Rating (BRR) | Constructive — Conditional Accumulation |
| 12-Month Price Target (Base) | $320–$330 |
| Upside Scenario (Earnings Beat + Cboe Predicts Traction + TMX Approval) | $340–$350 |
| Downside Scenario (Earnings Miss or Guidance Caution) | $285–$295 |
| Confidence Level | Moderate (55–60%) |
| Suitable For | Growth-oriented institutional mandates; total-return portfolios; not income-mandated accounts |
Synthesis
Cboe Global